Integrative Analysis Identified MCT4 as an Independent Prognostic Factor for Bladder Cancer

BACKGROUND: Bladder cancer is the 10th most common cancer and most common urothelial malignancy worldwide. Prognostic biomarkers for bladder cancer patients are required for individualized treatment. Monocarboxylate transporter 4 (MCT4), encoded by SLC16A3 gene, is a potential biomarker for bladder...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yang, Zhao, Bin, Yan, Wei-Hua, Xia, Yan, Wang, Zhi-Hui, Zheng, Guo-Yang, Wang, Wen-Da, Zhang, Yu-Shi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426349/
https://www.ncbi.nlm.nih.gov/pubmed/34513685
http://dx.doi.org/10.3389/fonc.2021.704857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8426349/
https://www.ncbi.nlm.nih.gov/pubmed/34513685
http://dx.doi.org/10.3389/fonc.2021.704857

Ejemplares similares